ViennaLab Diagnostics GmbH

Prevent effects of iron overload in patients with hereditary haemochromatosis (HH) by early genetic testing and treatment initiation.

Hereditary haemochromatosis is one of the most prevalent genetic disorders in the Northern European population. It is characterized by progressive accumulation of iron in various organs. ViennaLab assays identify the most frequent genetic variants causing iron overload.

 

Haemochromatosis

 

  • Hereditary haemochromatosis (HH) is an inherited iron overload disorder characterized by excessive absorption and deposition of iron.
  • HH is caused by mutations in the HFE, TFR2 or FPN1 genes.
  • Over time, iron deposition can lead to dysfunction and failure in multiple organs.
  • If left untreated, HH can lead to liver cirrhosis, liver cancer, diabetes, arthritis, and cardiopathies.
  • The primary goal in the management of HH is to identify patients and initiate treatment before irreversible damage occurs.
  • Therefore, early diagnosis and treatment initiation are essential to allow a virtually normal life for affected individuals.

Link to ACG Clinical Guideline

 

The IFUs are available in other European languages upon request. Please contact us at: This email address is being protected from spambots. You need JavaScript enabled to view it.

ProductReg. Stat.REFUnit SizeIFUBrochure
Haemochromatosis StripAssay® A IVDR CE0123 4-220 20 tests

PDF

Haemochromatosis StripAssay® B CE/IVD 4-210 20 tests

PDF

PDF

HFE C282Y RealFast™ Assay IVDR CE0123 7-130
7-133
100 rxn
32 rxn
HFE H63D RealFast™ Assay IVDR CE0123 7-140
7-143
100 rxn
32 rxn
HFE mpx RealFast™ Assay IVDR CE0123 7-135
7-138
100 rxn
32 rxn

We use Matomo to analyze the access to our website. We pass on information about your use of our website to our partners for analysis. Our partners may combine this information with other data that you have provided to them or that they have collected as part of your use of the services. I agree.

Deny Allow